| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.7B | $18.7B | $11.8B | $11.9B | $12.2B | $11.5B | $3.0B | $2.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | $0.8B | $0.5B |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $7.1B | $3.3B | $-2.5B | $-0.4B | $1.2B | $2.8B | $0.6B | $0.0B |
| EPS (Basic) | $6.41 | $2.92 | $-2.97 | $-0.54 | $1.46 | $3.52 | $0.69 | $0.64 |
| EPS (Diluted) | $6.39 | $2.92 | $-2.97 | $-0.54 | $1.46 | $3.51 | $0.69 | $0.64 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $57.1B | $56.3B | $55.5B | $38.5B | $40.6B | $41.4B | $40.0B | $20.7B |
| Current Assets | $13.1B | $12.3B | $7.5B | $6.5B | $7.7B | $8.5B | $6.3B | $5.3B |
| Cash & Equivalents | $7.6B | $3.6B | $3.0B | $2.9B | $5.0B | $5.5B | $2.2B | $3.4B |
| Total Liabilities | $23.1B | $26.2B | $26.3B | $18.9B | $18.7B | $17.5B | $17.6B | $9.2B |
| Current Liabilities | $5.7B | $7.5B | $6.0B | $2.9B | $2.7B | $3.4B | $2.4B | $1.8B |
| Stockholders' Equity | $33.9B | $29.9B | $29.0B | $19.4B | $22.0B | $23.0B | $21.4B | $10.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.3B | $6.4B | $2.8B | $3.2B | $4.3B | $4.9B | $2.9B | $1.8B |
| Investing Cash Flow | $0.6B | $-2.7B | $-1.0B | $-3.0B | $-1.9B | $0.1B | $-1.2B | $-1.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-7.0B | $-3.0B | $-1.6B | $-2.4B | $-3.0B | $-1.7B | $-2.8B | $-0.5B |